课题基金 / 基金详情

NEUROLOGIC PARANEOPLASTIC SYNDROME

NEUROLOGIC PARANEOPLASTIC SYNDROME
神经副肿瘤综合征
批准号:
3416547
负责人:
HENRY M FURNEAUX
金额:
$20.55万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-01 至 1995-08-31

项目摘要

项目成果

HENRY M FURNEAUX的其他基金

相似基金

相关文献

中文摘要
翻译
这项提议的基础是研究 抗体相关的副肿瘤综合征 虽然罕见,但这些 神经系统综合征是至关重要的,因为患者 针对人肿瘤抗原的高滴度抗体。 三 抗体相关的副肿瘤性神经综合征, 在这个实验室里发现和表征的, 在分子水平上进行研究。 这些综合征包括: 与小脑功能障碍相关的综合征和针对 抗卵巢肿瘤抗原;与感觉器官相关的Hu综合征 神经元病和针对小细胞肺癌的抗体 与眼阵挛和抗体相关的Ri综合征 针对乳腺肿瘤抗原。 网站或资源的可用性 高滴度人抗体提供了独特的机会:(a)分离 人肿瘤抗原(B)研究肿瘤特异性基因表达 机制等(c)了解人类抗肿瘤的分子基础 免疫反应
英文摘要
The basis of this proposal is to investigate the molecular biology of antibody-associated paraneoplastic syndromes. Although rare, these neurological syndromes are of crucial importance since the patients harbor high-titer antibodies directed against human tumor antigens. Three antibody-associated paraneoplastic neurological syndromes which have been discovered and characterized in this laboratory will be further investigated at the molecular level. These syndromes include: the Yo syndrome associated with cerebellar dysfunction and antibodies directed against ovarian tumor antigens; the Hu syndrome associated with sensory neuronopathy and antibodies directed against small cell lung cancer antigens; the Ri syndrome associated with opsoclonus and antibodies directed against breast tumor antigens. The availability of these high-titer human antibodies provide a unique opportunity to: (a) Isolate human tumor antigens (b) Investigate tumor specific gene expression mechanisms. (c) Understand the molecular basis of the human anti-tumor immune response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cannabinoid Receptor (CNR1) MicroRNAs and Addictive Disease
Cannabinoid Receptor (CNR1) MicroRNAs and Addictive Disease
REGULATION OF VEGF MRNA STABILITY BY HYPOXIA
REGULATION OF VEGF MRNA STABILITY BY HYPOXIA
海外基金